PCMH
PFE icon

Polymer Capital Management (HK)’s Pfizer PFE Stock Holding History

Polymer Capital Management (HK)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60,000
Closed -$1.74M – 215
2024
Q3 		$1.74M Hold
60,000
– – 0.4% 64
2024
Q2 		$1.68M Hold
60,000
– – 0.34% 65
2024
Q1 		$1.67M Hold
60,000
– – 0.42% 65
2023
Q4 		$1.73M Buy
+60,000
New +$1.81M 0.6% 45

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Polymer Capital Management (HK)'s PFE Position: Q4 2024 in Review

Polymer Capital Management (HK) sold out of Pfizer (PFE) in Q4 2024, closing a stake of 60,000 shares — an estimated $1.74M sold.

Polymer Capital Management (HK) first reported a position in PFE in Q4 2023 and held it in 4 quarters. The position peaked at $1.74M in Q3 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Polymer Capital Management (HK) reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 60,000 Pfizer shares in Q4 2024, an estimated $1.74M.
  • Polymer Capital Management (HK) first reported a position in Pfizer in Q4 2023 and held it in 4 quarters.
  • Polymer Capital Management (HK)'s Pfizer position peaked at $1.74M in Q3 2024.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Polymer Capital Management (HK)'s 13F filing for Q4 2024, filed 13 Feb 2025.